期刊文献+

系统性淋巴结清扫术治疗子宫内膜癌的疗效及安全性评价 被引量:7

下载PDF
导出
摘要 目的:讨论系统性淋巴结清扫术治疗子宫内膜癌的疗效和安全性。方法:选取笔者所在医院2013年2月-2014年8月收治的110例子宫内膜癌病患,按照随机数字表法分为两组,A组行双附件+全子宫切除+盆腔淋巴结清扫术,B组行双附件+全子宫切除+系统性腹主动脉、盆腔旁淋巴结清扫术。比较两组病患术后复发转移率、生存率及术后并发症情况。结果:术后B组复发转移率和生存率均明显优于A组,两组比较差异均有统计学意义;A组病患不全性肠梗阻0例,B组9例,两组比较差异有统计学意义(P<0.05),其余并发症比较差异均无统计学意义(P>0.05)。结论:系统性淋巴结清扫术可以有效提高病患的生存率,改善预后,虽术后并发症率有所增加,但仍在控制范围内,值得临床推广应用。
作者 宋波
机构地区 浏阳市人民医院
出处 《中外医学研究》 2015年第35期136-137,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献5

二级参考文献77

  • 1Pierluigi BP, Stefano B, Francesco M, et al. Systematic Pelvic Lymphadenectomy vs NoLymphadenectomy in Early StageEndometrial Carcinoma: Randomized Clini- calTrial[J]. JNCI,2008,100(23) :1 707-1 717.
  • 2ASTEC study group. Efficacy of systematic pelvic lymphadeneetomy inendometrial cancer (MRC ASTEC tri- al) : a randomised study[J].Lancet, 2009,373 : 125-136.
  • 3Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma .. clinical and histopathologic study of 540 patients[J]. Obstetrics and Gynecology, 1980,56(4) :419- 427.
  • 4Soderini A,Anchezar JP,Sardi JE. Role of adjuvant ra- diotherapy (RT) in intermediate risk( 1 b G2-3-1C) endo- metrioid carcinoma (EC)after extended staging surgery (ESS). Preliminary reports of arandomised trial[J]. International Journal of Gynecological Cancer, 2003,13 (Suppl) : 147-178.
  • 5The ASTEC/EN. 5 writing committee on behalf of the ASTEC/EN. 5 Study Group. Adjuvant external beam radiotherapy in the treatment ofendometrial cancer (MRC ASTEC and NCIC CTG EN. 5 randomised trials): pooled trial results, systematic review, and metaanalysis[J].Lancet, 2009,373 : 137-146.
  • 6Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate-risk endometrial adenocarcinoma: a Gynecologic Oneology Group study [J]. Gyneeol Oneol,2004,92(3) :744-751.
  • 7Creutzberg CL, van Putten WL, Koper PC, et al. Sur gery and postoperative radiotherapy versus surgery a lone for patients with stage-1 endometrialearcinoma multieentre randomised trial. PORTEC Study Group PostOperative Radiation Therapy in Endometrial Carci noma[J].Lancet,2000,355(9 213):1 404-1 411.
  • 8Bengt S,Britta N,Johanna M,et al. Intravaginal Brachy therapy in FIGOStage ILow-Risk Endometrial CancerA Controlled Randomized Study[J].International Journal of Gynecologic Cancer, 2009,19 : 873-878.
  • 9Nout RA, Smit V,Putter H, et al. Vaginal brachythe- rapy versus pelvic external beamradiotherapy for pa- tients with endometrial cancer ofhigh-intermediate risk (PORTEC-2): an open-label,non-inferiority, randomised trial[J]. Lancet,2010,375 :816-823.
  • 10Abu - Rustum NR, Khoury- Collado F, Pandit - Taskar N, et al. Sentinel lymph node mapping for g/'ade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol, 2009, 113: 163-169.

共引文献37

同被引文献59

  • 1吕玉峰,王云祥.子宫的淋巴流向[J].解剖学杂志,1985(2):102-105. 被引量:4
  • 2曹剑,李胜泽,刘雅莉,杨克虎.盆腔淋巴结清扫术对Ⅰ期子宫内膜癌的疗效研究[J].实用癌症杂志,2010,25(5):483-486. 被引量:8
  • 3李斌,吴令英,李淑敏,章文华,张蓉,马绍康.子宫内膜癌的预后影响因素分析[J].癌症,2004,23(9):1085-1088. 被引量:31
  • 4Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA: A Cancer J Clin, 2016, 66(1): 7-30.
  • 5Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, et al. Current issues in the management of endometrial cancer[J]. Mayo Clinic Proc, 2008, 83(1): 97-112.
  • 6Soliman P T, Frumovitz M, Spannuth W, et al. Lynaphadenectomy during endometrial cancer staging: Practice patterns among gynecologic oncologists[J]. Gynecol Oncol, 2010, 119(2): 291-294.
  • 7Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage Ⅰ and Ⅱ carcinoma of the endometrium:a Gynecologic Oncology Group study[J]. Gynecol Oncol, 1991, 40(1): 55-65.
  • 8Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study[J]. Cancer, 1987, 60(8 Suppl): 2035-2041.
  • 9Benedetti PP, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial[J]. J Natl Cancer Inst, 2008, 100(23): 1707-1716(10).
  • 10Kitchener HA, Qian Q, Amos C, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study[J]. Lancet, 2009, 373(9658): 125 -136.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部